The risk of venous thromboembolism (VTE) is known to be increased in patients with IBD. However, no specific consensus statements exist regarding the prevention of postoperative VTE in patients with this disease. The results of a large retrospective cohort study quantifying the risk of postoperative VTE in patients with IBD are discussed.
This is a preview of subscription content, log in via an institution to check access.
References
Grainge, M. J., West, J. & Card, T. R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375, 657–663 (2010).
Nguyen, G. C. & Sam, J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am. J. Gastroenterol. 103, 2272–2280 (2008).
Sam, J. J., Bernstein, C. N., Razik, R., Thanabalan, R. & Nguyen, G. C. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig. Dis. Sci. http://dx.doi.org/10.1007/s10620-012-2435-6.
Bergmann, J. F. et al. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb. Haemost. 103, 736–748 (2010).
Wallaert, J. B. et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQIP. Dis. Colon Rectum 55, 1138–1144 (2012).
Danese, S. et al. Inflammation and coagulation in inflammatory bowel disease: the clot thickens. Am. J. Gastroenterol. 102, 174–186 (2007).
Scarpa, M. et al. Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J. Surg. 34, 1629–1636 (2010).
Gould, M. K. et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141 (Suppl. 2), e227S–e277S (2012).
Shen, J., Ran, Z. H., Tong, J. L. & Xiao, S. D. Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis. Aliment. Pharmacol. Ther. 26, 653–663 (2007).
McLeod, R. S. et al. Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann. Surg. 233, 438–444 (2001).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Nguyen, G. Postoperative VTE prophylaxis in IBD. Nat Rev Gastroenterol Hepatol 10, 5–6 (2013). https://doi.org/10.1038/nrgastro.2012.233
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2012.233
- Springer Nature Limited
This article is cited by
-
Are IBD Patients Underscored when Determining Postoperative VTE Risk?
Journal of Gastrointestinal Surgery (2023)
-
Incidence of Venous Thromboembolism Following Proctectomy Is Greater in Ulcerative Colitis than in Malignancy or Crohn’s Disease
Journal of Gastrointestinal Surgery (2020)
-
The effect of pre-operative optimization on post-operative outcome in Crohn’s disease resections
International Journal of Colorectal Disease (2017)
-
Preoperative optimization of patients with inflammatory bowel disease undergoing gastrointestinal surgery: a systematic review
International Journal of Colorectal Disease (2017)
-
Fibrinogen production is enhanced in an in-vitro model of non-alcoholic fatty liver disease: an isolated risk factor for cardiovascular events?
Lipids in Health and Disease (2015)